Status:
COMPLETED
Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality
Lead Sponsor:
Assiut University
Conditions:
Treatment Resistant Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study we will assess the effect of Ketamine infusion on depressive symptoms and in particular its effect on Suicidal behavior, ideation and thoughts in patients with treatment- resistant MDD.
Detailed Description
A Twice repetition of IV infusion of 0.5 mg/kg of ketamine produces an antidepressant response in individuals with treatment-resistant MDD The work aims to: 1. To assess the onset of action and degr...
Eligibility Criteria
Inclusion
- Patients fulfilling diagnostic criteria of treatment-resistant MDD.
- Presence of suicidal risk.
- No comorbid medical or neurological conditions.
- Age above 18 years old.
- Both gender.
- Informed written consent from the patient or his legitimate.
Exclusion
- Presence of perceptual disturbance.
- History of sensitivity to ketamine.
- Refusal to participate in the study.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04101474
Start Date
September 1 2020
End Date
October 1 2021
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university
Asyut, Egypt